Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)

NCT02459080 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

619

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: TD-4208
DRUG: Placebo

Sponsor

Mylan Inc.

Collaborators

[object Object]